Features of the SIVmac transmembrane glycoprotein cytoplasmic domain that are important for Env functions.
The cytoplasmic domain (CD) of the SIVmac transmembrane protein (TM) can affect viral infectivity by modulating several Env functions, notably fusogenic capacity and incorporation into virions. In addition, envelopes with a truncated CD are counterselected in primary cells in culture and in vivo in rhesus macaques, suggesting a role for this domain in viral persistence. Here, we have used mutagenesis to examine specific features of the SIVmac TM CD, including the conserved C-terminal alpha helix and the overall length of the CD. Several mutations dramatically reduced and/or delayed virus infectivity in lymphoid cell lines. Detailed analysis of mutants revealed defects in envelope stability, fusogenic capacity, and virion incorporation. The primary defect associated with an envelope containing a 64-residue CD was rapid degradation. A mutant Env lacking the C-terminal alpha helix but encoding an exceptionally long CD (373 residues) was highly fusogenic but inefficiently incorporated into virions. A third mutant, containing amino acid substitutions designed to alter the charge density of the C-terminal helix, retained cytopathic properties and showed enhanced fusogenic capacity but replicated with delayed kinetics. Taken together, these results demonstrate that CD sequence variation entails functional "tradeoffs" that can involve optimization of certain Env functions at the expense of others.
Shacklett
B L
BL
ICGM-CNRS UPR 0415, Génétique des Virus, Institut Cochin de Génétique Moléculaire, Paris, France.
Denesvre
C
C
Boson
B
B
Sonigo
P
P
D000818:Animals; D019556:COS Cells; D002478:Cells, Cultured; D005822:Genetic Vectors; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000502:physiology*; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000302:isolation & purification; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000254:growth & development / Q000502:physiology*; D014759:Viral Envelope Proteins / Q000737:chemistry / Q000502:physiology*; D014760:Viral Fusion Proteins / Q000737:chemistry / Q000502:physiology*; D014779:Virus Replication
D008562:Membrane Glycoproteins; D012367:RNA, Viral; D014759:Viral Envelope Proteins; D014760:Viral Fusion Proteins